The Maharashtra Food and Drugs Administration (FDA) on Sunday (October 5, 2025), issued an urgent advisory calling for the immediate suspension of sale, distribution, and use of Coldrif Syrup, following reports of child fatalities in Madhya Pradesh and Rajasthan allegedly linked to the product.

The affected batch, Coldrif Syrup (Phenylephrine Hydrochloride, Chlorpheniramine Maleate), Batch No. SR-13, was manufactured in May 2025 by Sresan Pharma, based in Sunguvarchathiram, Kancheepuram district, Tamil Nadu. It is set to expire in April 2027. Laboratory analysis revealed the presence of Diethylene Glycol (DEG), a toxic chemical commonly found in industrial products like antifreeze. DEG ingestion can cause kidney failure and has been linked to multiple deaths.

Speaking to The Hindu , FD

See Full Page